Your shopping cart is currently empty

Pancreatic Polypeptide, rat acetate is an agonist of NPY receptor, with high affinity at NPYR4.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $238 | - | In Stock | |
| 5 mg | $567 | In Stock | In Stock | |
| 10 mg | $768 | In Stock | In Stock | |
| 25 mg | $1,120 | - | In Stock | |
| 50 mg | $1,530 | - | In Stock | |
| 100 mg | $2,070 | - | In Stock | |
| 200 mg | $2,800 | - | In Stock |
| Description | Pancreatic Polypeptide, rat acetate is an agonist of NPY receptor, with high affinity at NPYR4. |
| Targets&IC50 | NPYY5 receptor (HEK293 cells):0.24 nM, NPYY1 receptor (BHK-21 cells):530 nM, NPYY2 receptor (BHK-21 cells):> 500 nM, NPYY4 receptor (BHK-21 cells):51 nM |
| In vitro | Pancreatic Polypeptide, rat acetate is an agonist of NPY receptor, with high affinity at NPYR4. Pancreatic Polypeptide, rat acetate (1 μM) does not alter proliferation in BRIN BD11 or 1.1B4 beta-cells, but reverses the decreased cell viability in BRIN BD11 cells induced by streptozotocin. Pancreatic Polypeptide, rat acetate (0.1 nM-1 μM) shows no effect on insulin secretion from isolated mouse islets, and does not affect the membrane potential and (Ca2+)i levels in BRIN BD11 cells at 1 μM[1]. |
| In vivo | Pancreatic Polypeptide, rat acetate (25 nmol/kg bw, i.p.) reduces glucose-stimulated insulin concentrations but shows no effect on acute feeding behaviour in overnight fasted mice[1]. |
| Smiles | [H]N[C@H](C(N1CCC[C@H]1C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N2CCC[C@H]2C(N[C@H](C(N[C@H](C(N3CCC[C@H]3C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@]([C@@H](C)O)([H])C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(N[C@@H](CCC(N)=O)C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@]([C@@H](C)O)([H])C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(N[C@]([C@H](CC)C)([H])C(N[C@@H](CC(N)=O)C(N[C@]([C@@H](C)O)([H])C(N[C@@H](CC(C)C)C(N[C@]([C@@H](C)O)([H])C(N[C@@H](CCCNC(N)=N)C(N4CCC[C@H]4C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(O)=O)CC5=CC=C(O)C=C5)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC6=CC=C(O)C=C6)=O)=O)=O)=O)=O)=O)=O)CC7=CC=C(O)C=C7)=O)=O)C)=O)=O)=O)=O)CC8=CN=CN8)=O)=O)C)=O)CC9=CC=C(O)C=C9)=O)CC(O)=O)=O)=O)=O)CC%10=CC=C(O)C=C%10)=O)CCSC)=O)=O)=O)=O)=O)C |
| Sequence | Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| Sequence Short | APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 252.5 mg/mL, Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.